Paperpal Prime Logo

Journal of Clinical Psychopharmacology : Impact Factor & More

eISSN: 1533-712XpISSN: 0271-0749

Aims and Scope of Journal of Clinical Psychopharmacology

The Journal of Clinical Psychopharmacology is a peer-reviewed medical journal published by Lippincott Williams & Wilkins covering clinical psychopharmacology. It was founded by Richard I. Shader, MD in 1981 as the first journal of an international scope devoted solely to clinical psychopharmacology. David J. Greenblatt, MD served as Co-Editor-In-Chief. Drs. Shader and Greenblatt remained at the helm of the journal until both retired at the end of 2020. Anthony J. Rothschild, MD became JCP’s new Editor-in-Chief in January 2021. Less

Key Metrics

CiteScore
3.4
Impact Factor
< 5
SJR
Q1Medicine (all)
SNIP
0.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Clinical Psychopharmacology

Journal of Clinical Psychopharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Clinical Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Clinical Psychopharmacology

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.
  • 4 Aug 2026
  • Journal of clinical psychopharmacology
Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia: A Systematic Review and Meta-Analysis.
  • 31 Jul 2026
  • Journal of clinical psychopharmacology
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.
  • 28 Jul 2026
  • Journal of clinical psychopharmacology
Predicting Metabolic Adverse Effects of Lithium in Bipolar Disorder.
  • 27 Jul 2026
  • Journal of clinical psychopharmacology
Reply to "Reading the Signal: What Psychedelic Trials in Depression Still Can't Tell Us".
  • 27 Jul 2026
  • Journal of clinical psychopharmacology
A Manic Episode Associated With Levetiracetam Treatment in a Patient With Brain Tumor.
  • 27 Jul 2026
  • Journal of clinical psychopharmacology
Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.
  • 4 Aug 2026
  • Journal of clinical psychopharmacology
Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia: A Systematic Review and Meta-Analysis.
  • 31 Jul 2026
  • Journal of clinical psychopharmacology
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.
  • 28 Jul 2026
  • Journal of clinical psychopharmacology
Predicting Metabolic Adverse Effects of Lithium in Bipolar Disorder.
  • 27 Jul 2026
  • Journal of clinical psychopharmacology
Reply to "Reading the Signal: What Psychedelic Trials in Depression Still Can't Tell Us".
  • 27 Jul 2026
  • Journal of clinical psychopharmacology
A Manic Episode Associated With Levetiracetam Treatment in a Patient With Brain Tumor.
  • 27 Jul 2026
  • Journal of clinical psychopharmacology

FAQs on Journal of Clinical Psychopharmacology